vs

Adaptive Biotechnologies Corp(ADPT)与ALTISOURCE PORTFOLIO SOLUTIONS S.A.(ASPS)财务数据对比。点击上方公司名可切换其他公司

Adaptive Biotechnologies Corp的季度营收约是ALTISOURCE PORTFOLIO SOLUTIONS S.A.的1.7倍($70.9M vs $42.3M),Adaptive Biotechnologies Corp净利率更高(4.7% vs -16.8%,领先21.6%),Adaptive Biotechnologies Corp同比增速更快(35.1% vs 3.2%),过去两年Adaptive Biotechnologies Corp的营收复合增速更高(28.1% vs 3.6%)

ExpreS2ion Biotechnologies是一家丹麦生物技术企业,总部位于丹麦霍尔斯霍姆,专注于新型疫苗和免疫疗法产品的研发,在纳斯达克第一北增长市场瑞典板块挂牌上市。

Altisource Portfolio Solutions S.A.是面向抵押贷款、房地产及消费金融领域的全球服务商,为贷款机构、服务商、投资者等市场参与者提供技术、数据与运营解决方案,优化资产管理、房产交易等业务流程,提升客户运营效率。

ADPT vs ASPS — 直观对比

营收规模更大
ADPT
ADPT
是对方的1.7倍
ADPT
$70.9M
$42.3M
ASPS
营收增速更快
ADPT
ADPT
高出31.9%
ADPT
35.1%
3.2%
ASPS
净利率更高
ADPT
ADPT
高出21.6%
ADPT
4.7%
-16.8%
ASPS
两年增速更快
ADPT
ADPT
近两年复合增速
ADPT
28.1%
3.6%
ASPS

损益表 — Q1 FY2026 vs Q4 FY2025

指标
ADPT
ADPT
ASPS
ASPS
营收
$70.9M
$42.3M
净利润
$3.4M
$-7.1M
毛利率
73.6%
26.5%
营业利润率
-27.1%
-15.5%
净利率
4.7%
-16.8%
营收同比
35.1%
3.2%
净利润同比
18.2%
每股收益(稀释后)
$-1.02

绿色 = 该指标领先。财年不对齐时期间可能不同

8季度营收与利润趋势

并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配

营收
ADPT
ADPT
ASPS
ASPS
Q1 26
$70.9M
Q4 25
$71.7M
$42.3M
Q3 25
$94.0M
$41.9M
Q2 25
$58.9M
$43.3M
Q1 25
$52.4M
$43.4M
Q4 24
$47.5M
$41.0M
Q3 24
$46.4M
$40.5M
Q2 24
$43.2M
$39.1M
净利润
ADPT
ADPT
ASPS
ASPS
Q1 26
$3.4M
Q4 25
$-13.6M
$-7.1M
Q3 25
$9.5M
$-2.3M
Q2 25
$-25.6M
$16.7M
Q1 25
$-29.9M
$-5.3M
Q4 24
$-33.7M
$-8.7M
Q3 24
$-32.1M
$-9.3M
Q2 24
$-46.2M
$-8.3M
毛利率
ADPT
ADPT
ASPS
ASPS
Q1 26
73.6%
Q4 25
74.6%
26.5%
Q3 25
80.7%
27.1%
Q2 25
69.4%
30.1%
Q1 25
67.6%
30.7%
Q4 24
62.0%
30.3%
Q3 24
64.1%
29.8%
Q2 24
55.3%
32.5%
营业利润率
ADPT
ADPT
ASPS
ASPS
Q1 26
-27.1%
Q4 25
-17.8%
-15.5%
Q3 25
10.9%
1.2%
Q2 25
-42.5%
7.5%
Q1 25
-56.4%
7.5%
Q4 24
-71.3%
1.4%
Q3 24
-70.3%
2.7%
Q2 24
-109.6%
5.3%
净利率
ADPT
ADPT
ASPS
ASPS
Q1 26
4.7%
Q4 25
-18.9%
-16.8%
Q3 25
10.2%
-5.5%
Q2 25
-43.5%
38.5%
Q1 25
-56.9%
-12.1%
Q4 24
-71.0%
-21.3%
Q3 24
-69.1%
-23.0%
Q2 24
-107.0%
-21.1%
每股收益(稀释后)
ADPT
ADPT
ASPS
ASPS
Q1 26
Q4 25
$-0.08
$-1.02
Q3 25
$0.06
$-0.22
Q2 25
$-0.17
$1.48
Q1 25
$-0.20
$-0.09
Q4 24
$-0.22
$-4.72
Q3 24
$-0.22
$-2.61
Q2 24
$-0.31
$-2.33

资产负债表与财务实力

最新季度各公司的流动性、杠杆与账面价值一览

指标
ADPT
ADPT
ASPS
ASPS
现金及短期投资手头流动性
$77.6M
$26.6M
总债务越低越好
$191.1M
股东权益账面价值
$-110.2M
总资产
$505.9M
$139.8M
负债/权益比越低杠杆越低

8季度趋势,按日历期对齐

现金及短期投资
ADPT
ADPT
ASPS
ASPS
Q1 26
$77.6M
Q4 25
$70.5M
$26.6M
Q3 25
$55.0M
$28.6M
Q2 25
$43.2M
$30.0M
Q1 25
$50.6M
$30.8M
Q4 24
$47.9M
$29.8M
Q3 24
$38.1M
$28.3M
Q2 24
$59.8M
$29.7M
总债务
ADPT
ADPT
ASPS
ASPS
Q1 26
Q4 25
$191.1M
Q3 25
$192.5M
Q2 25
$193.9M
Q1 25
$195.0M
Q4 24
$230.5M
Q3 24
Q2 24
股东权益
ADPT
ADPT
ASPS
ASPS
Q1 26
Q4 25
$218.8M
$-110.2M
Q3 25
$204.4M
$-104.2M
Q2 25
$179.7M
$-102.7M
Q1 25
$190.4M
$-119.8M
Q4 24
$202.7M
$-157.4M
Q3 24
$223.8M
$-149.4M
Q2 24
$241.6M
$-140.8M
总资产
ADPT
ADPT
ASPS
ASPS
Q1 26
$505.9M
Q4 25
$512.7M
$139.8M
Q3 25
$490.6M
$139.9M
Q2 25
$496.6M
$142.9M
Q1 25
$510.9M
$145.7M
Q4 24
$539.4M
$143.6M
Q3 24
$558.5M
$144.5M
Q2 24
$584.9M
$146.6M

现金流与资本效率

扣除再投资后实际产生的现金。现金流比净利润更难造假

指标
ADPT
ADPT
ASPS
ASPS
经营现金流最新季度
$-505.0K
自由现金流经营现金流 - 资本支出
$-525.0K
自由现金流率自由现金流/营收
-1.2%
资本支出强度资本支出/营收
0.0%
现金转化率经营现金流/净利润
过去12个月自由现金流最近4个季度
$-5.1M

8季度趋势,按日历期对齐

经营现金流
ADPT
ADPT
ASPS
ASPS
Q1 26
Q4 25
$2.1M
$-505.0K
Q3 25
$-7.1M
$718.0K
Q2 25
$-12.4M
$-306.0K
Q1 25
$-28.5M
$-5.0M
Q4 24
$-12.5M
$-1.4M
Q3 24
$-27.1M
$-1.6M
Q2 24
$-17.3M
$180.0K
自由现金流
ADPT
ADPT
ASPS
ASPS
Q1 26
Q4 25
$1.4M
$-525.0K
Q3 25
$-7.5M
$697.0K
Q2 25
$-13.1M
$-309.0K
Q1 25
$-29.7M
$-5.0M
Q4 24
$-12.6M
$-1.4M
Q3 24
$-27.4M
Q2 24
$-19.0M
自由现金流率
ADPT
ADPT
ASPS
ASPS
Q1 26
Q4 25
2.0%
-1.2%
Q3 25
-8.0%
1.7%
Q2 25
-22.2%
-0.7%
Q1 25
-56.7%
-11.5%
Q4 24
-26.5%
-3.4%
Q3 24
-59.0%
Q2 24
-44.1%
资本支出强度
ADPT
ADPT
ASPS
ASPS
Q1 26
Q4 25
0.9%
0.0%
Q3 25
0.4%
0.1%
Q2 25
1.1%
0.0%
Q1 25
2.4%
0.1%
Q4 24
0.2%
0.0%
Q3 24
0.7%
0.0%
Q2 24
4.0%
0.0%
现金转化率
ADPT
ADPT
ASPS
ASPS
Q1 26
Q4 25
Q3 25
-0.75×
Q2 25
-0.02×
Q1 25
Q4 24
Q3 24
Q2 24

财务流量对比

营收 → 毛利润 → 营业利润 → 净利润流向图

业务分部营收拆解

ADPT
ADPT

暂无分部数据

ASPS
ASPS

Services$39.9M94%
Revenue Relatedto Technology Platformsand Professional Services$2.4M6%

相关对比